Dr Tim Card

Dr Tim Card

Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

+44 115 823 1346 View full bio
Clinical Associate Professor

Dr Card studied medicine in Bristol, and received his postgraduate medical training in Leicester and Oxford. He completed a PhD in Nottingham, and after completion of his clinical training returned as Clinical associate Professor.

Publications
Title
Rate of venous thromboembolism by cancer type compared to the general population using multiple link
Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other c
Adrenergic blockers and the risk for common solid cancers: a case-control study
MDM2 Expression in the Progression of Barrett’s Oesophagus
Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding
Risks of major congenital anomalies in children born to women with inflammatory bowel disease: a Uni
Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kin
All-cause and cause-specific mortality rates of patients treated for alcohol use disorders: a meta-a
Causes of Death in People With Celiac Disease Spanning the Pre- and Post-Serology Era: A Population-
An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of d
How to Critically Read the GI Epidemiology Literature
An increased risk of urinary tract infection precedes development of primary biliary cirrhosis
Excess Long-Term Mortality following Non-Variceal Upper Gastrointestinal Bleeding: A Population-Base
Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study
Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Pract
Letter: the burden of co-morbidity in the population contributes more to upper gastrointestinal blee
Upper gastrointestinal haemorrhage and deprivation: a nationwide cohort study of health inequality i
Comorbidities Affect Risk of Nonvariceal Upper Gastrointestinal Bleeding
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previous
Risk of Cardiovascular and Cerebrovascular Events in Primary Biliary Cirrhosis: A Population-Based C
Cause-Specific Mortality of People With Barrett’s Esophagus Compared With the General Population: A
Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their
The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformi
Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Re
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom
Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a popula
Hip fracture risk in patients with alcoholic cirrhosis: A population-based study using English and D
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primar
Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based s
The Pattern of Underlying Cause of Death in Patients with Inflammatory Bowel Disease in England: A R
All-cause mortality in people with cirrhosis compared with the general population: a population-base
Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based s
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis i
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis i
The communication of a secondary care diagnosis of autoimmune hepatitis to primary care practitioner
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fat
Prevalence of clinically significant liver disease within the general population, as defined by non-
Become a Volunteer

Click here to find out how you can participate in our clinical trials
Patient & Public Involvement

Find out how you can help the Nottingham BRC to shape our research trials